Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Neurology, University of California, Davis, Sacramento, California, USA.
Acad Emerg Med. 2024 Sep;31(9):848-859. doi: 10.1111/acem.14919. Epub 2024 Apr 21.
Large-vessel occlusion (LVO) stroke represents one-third of acute ischemic stroke (AIS) in the United States but causes two-thirds of poststroke dependence and >90% of poststroke mortality. Prehospital LVO stroke detection permits efficient emergency medical systems (EMS) transport to an endovascular thrombectomy (EVT)-capable center. Our primary objective was to determine the feasibility of using a cranial accelerometry (CA) headset device for prehospital LVO stroke detection. Our secondary objective was development of an algorithm capable of distinguishing LVO stroke from other conditions.
We prospectively enrolled consecutive adult patients suspected of acute stroke from 11 study hospitals in four different U.S. geographical regions over a 21-month period. Patients received device placement by prehospital EMS personnel. Headset data were matched with clinical data following informed consent. LVO stroke diagnosis was determined by medical chart review. The device was trained using device data and Los Angeles Motor Scale (LAMS) examination components. A binary threshold was selected for comparison of device performance to LAMS scores.
A total of 594 subjects were enrolled, including 183 subjects who received the second-generation device. Usable data were captured in 158 patients (86.3%). Study subjects were 53% female and 56% Black/African American, with median age 69 years. Twenty-six (16.4%) patients had LVO and 132 (83.6%) were not LVO (not-LVO AIS, 33; intracerebral hemorrhage, nine; stroke mimics, 90). COVID-19 testing and positivity rates (10.6%) were not different between groups. We found a sensitivity of 38.5% and specificity of 82.7% for LAMS ≥ 4 in detecting LVO stroke versus a sensitivity of 84.6% (p < 0.0015 for superiority) and specificity of 82.6% (p = 0.81 for superiority) for the device algorithm (CA + LAMS).
Obtaining adequate recordings with a CA headset is highly feasible in the prehospital environment. Use of the device algorithm incorporating both CA and LAMS data for LVO detection resulted in significantly higher sensitivity without reduced specificity when compared to the use of LAMS alone.
在美国,大血管闭塞(LVO)卒中占急性缺血性卒中(AIS)的三分之一,但导致三分之二的卒中后依赖和 90%以上的卒中后死亡率。院前 LVO 卒中检测可实现高效的紧急医疗服务(EMS)转运至血管内血栓切除术(EVT)中心。我们的主要目标是确定使用颅加速度计(CA)耳机设备进行院前 LVO 卒中检测的可行性。我们的次要目标是开发一种能够区分 LVO 卒中和其他情况的算法。
我们前瞻性纳入了来自美国四个不同地理区域的 11 家研究医院的连续成年疑似急性卒中患者,研究时间为 21 个月。患者接受院前 EMS 人员的设备放置。在获得知情同意后,将耳机数据与临床数据相匹配。LVO 卒中的诊断是通过病历回顾确定的。该设备使用设备数据和洛杉矶运动量表(LAMS)检查组件进行训练。选择二进制阈值以比较设备性能与 LAMS 评分。
共纳入 594 例患者,其中 183 例患者接受了第二代设备。158 例患者(86.3%)获得了可用数据。研究对象中 53%为女性,56%为黑人/非裔美国人,中位年龄为 69 岁。26 例(16.4%)患者存在 LVO,132 例(83.6%)患者不存在 LVO(非 LVO-AIS33 例,脑出血 9 例,卒中模拟 90 例)。COVID-19 检测和阳性率(10.6%)在两组间无差异。我们发现,LAMS≥4 用于检测 LVO 卒中的敏感性为 38.5%,特异性为 82.7%,而设备算法(CA+LAMS)的敏感性为 84.6%(p<0.0015 具有优势),特异性为 82.6%(p=0.81 具有优势)。
在院前环境中,使用 CA 耳机获得足够的记录是高度可行的。与单独使用 LAMS 相比,使用同时包含 CA 和 LAMS 数据的设备算法进行 LVO 检测可显著提高敏感性而不降低特异性。